systematic_review
    2013
    High Quality

    Ginkgo biloba for intermittent claudication

    Nicolai SP, et al.

    Published in Cochrane Database of Systematic Reviews

    Key Findings

    Overall, there is no evidence that Ginkgo biloba has a clinically significant benefit for patients with peripheral arterial disease.

    Conclusions

    Overall, there is no evidence that Ginkgo biloba has a clinically significant benefit for patients with peripheral arterial disease.

    Supplements Studied

    Overall, there is no evidence that Ginkgo biloba has a clinically significant benefit for patients with peripheral arterial disease.

    Related Health Concerns

    Poor Circulation
    Peripheral Artery Disease

    Study Details

    Year:2013
    Sample Size:739
    Duration:24 weeks
    Quality Score:9/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.